Sumary of The benefits of a COVID vaccine far outweigh the small risk of treatable heart inflammation:
- Repeated COVID-19 outbreaks in Australia have once again highlighted the need for rapid and widespread vaccination.
- We are extremely fortunate the global scientific community has been able to develop a handful of highly effective vaccines in such a short time.
- As with any vaccine or medicine, the COVID vaccines do carry small risks.
- The rare blood clotting disorder caused by the AstraZeneca vaccine — thrombosis with thrombocytopenia syndrome, or TTS — has largely dominated the headlines.
- But we’re also seeing reports of a potentially increased risk of myocarditis and pericarditis (heart inflammation) following the mRNA COVID-19 vaccines, developed by Pfizer/BioNTech and Moderna.
- There are three main types of heart inflammation: endocarditis, myocarditis, and pericarditis.
- These involve inflammation of the inner lining of the heart, the heart muscle, and the outer lining of the heart respectively.
- Viruses, including the SARS-CoV-2 virus that causes COVID-19, are the most common cause of myocarditis and pericarditis.